Lombard Odier Asset Management (Usa) Corp Gilead Sciences, Inc. Call Options Transaction History

Lombard Odier Asset Management (Usa) Corp

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $8.66 Million - $10.9 Million	-130,000 Reduced 46.43%	150,000 $12.6 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $5.68 Million - $6.56 Million	-90,000 Reduced 24.32%	280,000 $19.2 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $26.5 Million - $32.3 Million	370,000 New	370,000 $27.1 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $2.32 Million - $2.9 Million	40,000 Added 14.29%	320,000 $19 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $4.5 Million - $5.13 Million	-75,000 Reduced 21.13%	280,000 $18.1 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $1.13 Million - $1.29 Million	-20,000 Reduced 5.33%	355,000 $20.7 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $3.11 Million - $3.9 Million	50,000 Added 15.38%	375,000 $23.7 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $1.09 Million - $1.26 Million	15,000 Added 4.84%	325,000 $25 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $9.86 Million - $10.8 Million	160,000 Added 106.67%	310,000 $20.1 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $9.28 Million - $10.4 Million	150,000 New	150,000 $10.1 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $4.06 Million - $4.55 Million	-65,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $1.46 Million - $1.78 Million	-20,000 Reduced 23.53%	65,000 $4.9 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $6.05 Million - $7.1 Million	85,000	85,000 $6.09 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Usa) Corp, based on Form 13F filings with the SEC.

Stay updated on Lombard Odier Asset Management (Usa) Corp with notifications on news.